Cargando…
EGFR mutation status in Tunisian non-small-cell lung cancer patients evaluated by mutation-specific immunohistochemistry
BACKGROUND: Screening mutations in epidermal growth factor receptor (EGFR) to analyze non-small-cell lung cancer (NSCLC) profile is the criterion to choose the best therapeutic strategy. New Oncology guidelines recommend EGFR mutation analysis before prescribing tyrosine kinase inhibitors (TKIs) tre...
Autores principales: | Mraihi, Zohra, Ben Amar, Jihen, Bouacha, Hend, Rammeh, Soumaya, Hila, Lamia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085720/ https://www.ncbi.nlm.nih.gov/pubmed/30092812 http://dx.doi.org/10.1186/s12890-018-0706-5 |
Ejemplares similares
-
PIK3CA mutations in breast cancer: A Tunisian series
por: Ben Rekaya, Mariem, et al.
Publicado: (2023) -
Identification of EGFR Mutations by Immunohistochemistry with EGFR Mutation–Specific Antibodies in Biopsy and Resection Specimens from Pulmonary Adenocarcinoma
por: Kim, Chi Hong, et al.
Publicado: (2015) -
First case report of Cohen syndrome in the Tunisian population caused by VPS13B mutations
por: Rejeb, Imen, et al.
Publicado: (2017) -
MCP-1, CCR2 and CCR5 polymorphisms in Tunisian patients with atopic asthma
por: Dhaouadi, Tarak, et al.
Publicado: (2011) -
Identification of Novel BRCA1 and RAD50 Mutations Associated With Breast Cancer Predisposition in Tunisian Patients
por: Mighri, Najah, et al.
Publicado: (2020)